Background: Increasing evidence suggests that abdominal aortic aneurysm (AAA) is a T-cell-mediated autoimmune condition. This study investigates the epigenetic modifications that occur in the T cells of AAA patients and evaluates the correlation of these modifications with disease development. Methods and Results: Peripheral T cells were collected from 101 AAA patients and 102 healthy controls (HCs). DNA methylation and histone acetylation levels were measured by ELISA. Methyl-CpG-binding domain, DNA methyltransferase (DNMT) and histone deacetylase (HDAC) mRNA levels were determined by real-time PCR. DNA from the T cells of the AAA patients exhibited significant hypomethylation compared with the HCs (1.6-fold, p < 0.0001). Expression of DNMT1 at the mRNA level in the T cells of the AAA patients was 1.52-fold lower than that of the HCs (p < 0.0001). The extent of DNA methylation in the AAA patients was negatively correlated with the corresponding aortic diameter (r = -0.498, p < 0.0001). H3 (1.59-fold, p < 0.0001) and H3K14 (2.15-fold, p < 0.0001) acetylation levels in the T cells of the AAA patients were higher than those of the HCs, but the HDAC1 mRNA level was 2.33-fold lower than that of the HCs (p < 0.0001). Conclusions: DNA methylation and the histone modification status are significantly altered in the T cells of AAA patients. These changes could play a pivotal role in the activation of pathological immune responses and may influence AAA development.

Kent KC: Clinical practice. Abdominal aortic aneurysms. N Engl J Med 2014;371:2101-2108.
LeFevre ML: Screening for abdominal aortic aneurysm: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med 2014;161:281-290.
Jagadesham VP, Scott DJ, Carding SR: Abdominal aortic aneurysms: an autoimmune disease? Trends Mol Med 2008;14:522-529.
Eagleton MJ: Inflammation in abdominal aortic aneurysms: cellular infiltrate and cytokine profiles. Vascular 2012;20:278-283.
Ait-Oufella H, Wang Y, Herbin O, Bourcier S, Potteaux S, Joffre J, Loyer X, Ponnuswamy P, Esposito B, Dalloz M, Laurans L, Tedgui A, Mallat Z: Natural regulatory T cells limit angiotensin II-induced aneurysm formation and rupture in mice. Arterioscler Thromb Vasc Biol 2013;33:2374-2379.
Zhang J, Bockler D, Ryschich E, Klemm K, Schumacher H, Schmidt J, Allenberg JR: Impaired Fas-induced apoptosis of T lymphocytes in patients with abdominal aortic aneurysms. J Vasc Surg 2007;45:1039-1046.
Yin M, Zhang J, Wang Y, Wang S, Bockler D, Duan Z, Xin S: Deficient CD4+CD25+ T regulatory cell function in patients with abdominal aortic aneurysms. Arterioscler Thromb Vasc Biol 2010;30:1825-1831.
Bird A: Perceptions of epigenetics. Nature 2007;447:396-398.
Lu Q: The critical importance of epigenetics in autoimmunity. J Autoimmun 2013;41:1-5.
Gupta B, Hawkins RD: Epigenomics of autoimmune diseases. Immunol Cell Biol 2015;93:271-276.
Meda F, Folci M, Baccarelli A, Selmi C: The epigenetics of autoimmunity. Cell Mol Immunol 2011;8:226-236.
Krishna SM, Dear AE, Norman PE, Golledge J: Genetic and epigenetic mechanisms and their possible role in abdominal aortic aneurysm. Atherosclerosis 2010;212:16-29.
Krishna SM, Dear A, Craig JM, Norman PE, Golledge J: The potential role of homocysteine-mediated DNA methylation and associated epigenetic changes in abdominal aortic aneurysm formation. Atherosclerosis 2013;228:295-305.
Parry L, Clarke AR: The roles of the methyl-CPG binding proteins in cancer. Genes Cancer 2011;2:618-630.
Schubeler D: Function and information content of DNA methylation. Nature 2015;517:321-326.
Webster AL, Yan MS, Marsden PA: Epigenetics and cardiovascular disease. Can J Cardiol 2013;29:46-57.
Martinez SR, Gay MS, Zhang L: Epigenetic mechanisms in heart development and disease. Drug Discov Today 2015;20:799-811.
Das PM, Singal R: DNA methylation and cancer. J Clin Oncol 2004;22:4632-4642.
Renaudineau Y, Youinou P: Epigenetics and autoimmunity, with special emphasis on methylation. Keio J Med 2011;60:10-16.
Zhang P, Su Y, Chen H, Zhao M, Lu Q: Abnormal DNA methylation in skin lesions and PBMCs of patients with psoriasis vulgaris. J Dermatol Sci 2010;60:40-42.
Ballestar E: Epigenetic alterations in autoimmune rheumatic diseases. Nat Rev Rheumatol 2011;7:263-271.
Luo Y, Li Y, Su Y, Yin H, Hu N, Wang S, Lu Q: Abnormal DNA methylation in T cells from patients with subacute cutaneous lupus erythematosus. Br J Dermatol 2008;159:827-833.
Lei W, Luo Y, Lei W, Luo Y, Yan K, Zhao S, Li Y, Qiu X, Zhou Y, Long H, Zhao M, Liang Y, Su Y, Lu Q: Abnormal DNA methylation in CD4+ T cells from patients with systemic lupus erythematosus, systemic sclerosis, and dermatomyositis. Scand J Rheumatol 2009;38:369-374.
Forester ND, Cruickshank SM, Scott DJ, Carding SR: Functional characterization of T cells in abdominal aortic aneurysms. Immunology 2005;115:262-270.
Wilson CB, Makar KW, Shnyreva M, Fitzpatrick DR: DNA methylation and the expanding epigenetics of T cell lineage commitment. Semin Immunol 2005;17:105-119.
Pearce EL, Shen H: Making sense of inflammation, epigenetics, and memory CD8+ T-cell differentiation in the context of infection. Immunol Rev 2006;211:197-202.
Zhao M, Liang G, Wu X, Wang S, Zhang P, Su Y, Yin H, Tan Y, Zhang J, Lu Q: Abnormal epigenetic modifications in peripheral blood mononuclear cells from patients with alopecia areata. Br J Dermatol 2012;166:226-273.
Tessarz P, Kouzarides T: Histone core modifications regulating nucleosome structure and dynamics. Nat Rev Mol Cell Biol 2014;15:703-708.
Picascia A, Grimaldi V, Pignalosa O, De Pascale MR, Schiano C, Napoli C: Epigenetic control of autoimmune diseases: from bench to bedside. Clin Immunol 2015;157:1-15.
Dieker J, Muller S: Epigenetic histone code and autoimmunity. Clin Rev Allergy Immunol 2010;39:78-84.
Fernandez-Sanchez A, Baragano Raneros A, Carvajal Palao R, Sanz AB, Ortiz A, Ortega F, Suarez-Alvarez B, Lopez-Larrea C: DNA demethylation and histone H3K9 acetylation determine the active transcription of the NKG2D gene in human CD8+ T and NK cells. Epigenetics 2013;8:66-78.
Zhao S, Long H, Lu Q: Epigenetic perspectives in systemic lupus erythematosus: pathogenesis, biomarkers, and therapeutic potentials. Clin Rev Allergy Immunol 2010;39:3-9.
Vojinovic J, Damjanov N: HDAC inhibition in rheumatoid arthritis and juvenile idiopathic arthritis. Mol Med 2011;17:397-403.
Szyf M: Epigenetic therapeutics in autoimmune disease. Clin Rev Allergy Immunol 2010;39:62-77.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.